News & Updates
Filter by Specialty:

Maternal TDF, infant HBV vax, HBIg-free strategy prevent infant hep B
In the absence of infant hepatitis B immune globulin (HBIg), maternal tenofovir disoproxil fumarate (TDF) prophylaxis combined with infant hepatitis B virus (HBV) immunization provide sufficient protection against HBV infection in infants, findings from the iTAP-2 study suggest. However, the risk of infection was not demonstrably below 2 percent.
Maternal TDF, infant HBV vax, HBIg-free strategy prevent infant hep B
01 Apr 2025
Annual T2D screening delivers economic gains in women with GDM history
A study from Singapore shows that universal annual screening for type 2 diabetes (T2D) cuts the economic and societal burden of delayed T2D diagnosis in women with a history of gestational diabetes (GDM).
Annual T2D screening delivers economic gains in women with GDM history
26 Mar 2025
Prenatal BPG delivery: 9-day treatment interval linked to higher risk of congenital syphilis
When treating late latent syphilis during pregnancy, extending the interval between benzathine penicillin G (BPG) doses to 9 days may put newborns at risk of congenital infection relative to 6–8-day intervals, according to new research.